CONTINENTAL STRATEGY, LLC

Lobbying for VIVEX BIOLOGICS · regenerative medicine company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Florida · $120,000.00 income · posted Jan 19, 2026

Lobbying activity 2

Science/Technology

regenerative and innovative medical solutions

Health Issues

regenerative and innovative medical solutions

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.